HTG Molecular Diagnostics, Inc. Provides Update Regarding Companion Diagnostic Development Programs

TUCSON, Ariz. , Oct. 10, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today provided an update regarding its ongoing efforts related to the development, manufacture and commercialization of